Atlas Trials

Everolimus for Children With Recurrent or Progressive Ependymoma

Clinical trial NCT02155920 · COMPLETED

Trial details

NCT number
NCT02155920
Sponsor
University of Texas Southwestern Medical Center
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Recurrent Childhood Ependymoma
Start date
2015-02-01
Primary completion
2023-07-14
Enrollment
11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.